Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome

Journal of Investigative Dermatology

Volumn 136, Issue 7, 2016, Pages 1490-1499

  Prasad, Aparna ^a,b,c,d   Rabionet, Raquel ^a,b,c,d   Espinet, Blanca ^d   Zapata, Luis ^a,b,c   Puiggros, Anna ^d   Melero, Carme ^d   Puig, Anna ^a,b,c,d   Sarria Trujillo, Yaris ^a,b,c,d   Ossowski, Stephan ^a,b   Garcia Muret, Maria P ^e   Estrach, Teresa ^f   Servitje, Octavio ^g   Lopez Lerma, Ingrid ^h   Gallardo, Fernando ^d   Pujol, Ramon M ^d   Estivill, Xavier ^a,b,c,d,i  

^a BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Hospital Sant Pau   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PROTEIN KINASE TYK2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR ZEB1; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CBLB GENE; CELL DIFFERENTIATION; CHROMOSOME 17; CHROMOSOME 4; CHROMOSOME BAND; COPY NUMBER VARIATION; DSC1 GENE; ENDOPLASMIC RETICULUM; GENE; GENE FUSION; GENE MUTATION; HUMAN; ITPR1 GENE; ITPR2 GENE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; RAG2 GENE; RASA2 GENE; RIPK2 GENE; SEZARY SYNDROME; SOMATIC MUTATION; AGED; CHROMOSOME ABERRATION; CUTANEOUS T CELL LYMPHOMA; FEMALE; GENE DELETION; GENE DUPLICATION; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SKIN TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DELETION; GENE DUPLICATION; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS, FUSION; SEQUENCE ANALYSIS, RNA; SEZARY SYNDROME; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84992490318     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.03.024     Document Type: Article

References (74)

1. 1000 Genomes Project Consortium, 2010 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467 (2010), 1061–1073.
2. Agar, N.S., Wedgeworth, E., Crichton, S., Mitchell, T.J., Cox, M., Ferreira, S., et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 28 (2010), 4730–4739.
3. Azoulay-Zohar, H., Israelson, A., Abu-Hamad, S., Shoshan-Barmatz, V., In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 377 (2004), 347–355.
4. Bakkenist, C., Kastan, M., DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003), 499–506.
5. Bandapalli, O.R., Schuessele, S., Kunz, J.B., Rausch, T., Stütz, A.M., Tal, N., et al. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse. Haematologica 99 (2014), e188–e192.
6. Bassaganyas, L., Bea, S., Escaramis, G., Tornador, C., Salaverria, I., Zapata, L., et al. Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis. Leukemia 27 (2013), 2376–2379.
7. Beccuti, M., Carrara, M., Cordero, F., Lazzarato, F., Donatelli, S., Nadalin, F., et al. Chimera: a bioconductor package for secondary analysis of fusion products. Bioinformatics 30 (2014), 3556–3557.
8. Bertin, J., Wang, L., Guo, Y., Jacobson, M., Poyet, J., Srinivasula, S., et al. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 276 (2001), 11877–11882.
9. Bleeker, F.E., Lamba, S., Rodolfo, M., Scarpa, A., Leenstra, S., Vandertop, W.P., et al. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes. Hum Mutat 30 (2009), E451–E459.
10. Brito-Babapulle, V., Maljaie, S.H., Matutes, E., Hedges, M., Yuille, M., Catovsky, D., Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization. Br J Haematol 96 (1997), 724–732.
11. Callet-Bauchu, E., Salles, G., Gazzo, S., Dalle, S., Berger, F., Hayette, S., Identification of a novel e8/a4 BCR/ABL fusion transcript in a case of a transformed Sezary syndrome. Haematologica 92 (2007), 1277–1278.
12. Caprini, E., Cristofoletti, C., Arcelli, D., Fadda, P., Citterich, M., Sampogna, F., et al. Identification of key regions and genes important in the pathogenesis of Sezary syndrome by combining genomic and expression microarrays. Cancer Res 69 (2009), 8438–8446.
13. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2 (2012), 401–404.
14. Choi, J., Goh, G., Walradt, T., Hong, B.S., Bunick, C.G., Chen, K., et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet 47 (2015), 1011–1019.
15. Cibulskis, K., Lawrence, M.S., Carter, S.L., Sivachenko, A., Jaffe, D., Sougnez, C., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31 (2013), 213–219.
16. da Silva Almeida, A.C., Abate, F., Khiabanian, H., Martinez-Escala, E., Guitart, J., Tensen, C.P., et al. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. Nat Genet 47 (2015), 1465–1470.
17. DePristo, M.A., Banks, E., Poplin, R., Garimella, K.V., Maguire, J.R., Hartl, C., et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43 (2011), 491–498.
18. Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481 (2012), 506–510.
19. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., et al. STAR:ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
20. Elkin, S.K., Ivanov, D., Ewalt, M., Ferguson, C.G., Hyberts, S.G., Sun, Z.Y., et al. A PHD finger motif in the C terminus of RAG2 modulates recombination activity. J Biol Chem 280 (2005), 28701–28710.
21. Elly, C., Witte, S., Zhang, Z., Rosnet, O., Lipkowitz, S., Altman, A., et al. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 18 (1999), 1147–1156.
22. Entrez gene. https://www.ncbi.nlm.nih.gov/gene/2194; 2008 (accessed October 2015).
23. Espinet, B., Salido, M., Pujol, R., Florensa, L., Gallardo, F., Domingo, A., et al. Genetic characterization of Sezary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situ hybridization. Haematologica 89 (2004), 165–173.
24. Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBIoPortal. Sci Signal, 6, 2013, pl1.
25. Gonzalez-Perez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M.P., Jene-Sanz, A., et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat Methods 10 (2013), 1081–1082.
26. Hao, Q., Li, T., Zhang, X., Gao, P., Qiao, P., Li, S., et al. Expression and roles of fatty acid synthase in hepatocellular carcinoma. Oncol Rep 32 (2014), 2471–2476.
27. Hogan, M.C., Griffin, M.D., Rossetti, S., Torres, V.E., Ward, C.J., Harris, P.C., PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Hum Mol Genet 12 (2003), 685–698.
28. Johnson, G.A., Dewald, G.W., Strand, W.R., Winkelmann, R.K., Chromosome studies in 17 patients with the Sézary syndrome. Cancer 55 (1985), 2426–2433.
29. Karenko, L., Hahtola, S., Paivinen, S., Karhu, R., Syrja, S., Kahkonen, M., et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 65 (2005), 8101–8110.
30. Karenko, L., Hyytinen, E., Sarna, S., Ranki, A., Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 108 (1997), 22–29.
31. Khan, K., Hardy, R., Haq, A., Ogunbiyi, O., Morton, D., Chidgey, M., Desmocollin switching in colorectal cancer. Br J Cancer 95 (2006), 1367–1370.
32. Kiel, M., Sahasrabuddhe, A., Rolland, D., Velusamy, T., Chung, F., Schaller, M., et al. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome. Nat Comm, 6, 2015, 8470.
33. Kontro, M., Kuusanmäki, H., Eldfors, S., Burmeister, T., Andersson, E.I., Bruserud, O., et al. Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia. Leukemia 28 (2014), 1738–1742.
34. Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., et al. Circos: an information aesthetic for comparative genomics. Genome Res 19 (2009), 1639–1645.
35. Kulke, M.H., Freed, E., Chiang, D.Y., Philips, J., Zahrieh, D., Glickman, J.N., et al. High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss. Genes Chromosom Cancer 47 (2008), 591–603.
36. Ley, T.J., Mardis, E.R., Ding, L., Fulton, B., McLellan, M.D., Chen, K., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456 (2008), 66–72.
37. Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25 (2009), 1754–1760.
38. Liang, Y., Zhu, Y., Xia, Y., Peng, H., Yang, X.K., Liu, Y.Y., et al. Therapeutic potential of tyrosine kinase 2 in autoimmunity. Expert Opin Ther Targets 18 (2014), 571–580.
39. Limon, J., Nedoszytko, B., Brozek, I., Hellmann, A., Zajaczek, S., Lubiński, J., et al. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome. Cancer Genet Cytogenet 83 (1995), 75–81.
40. Liu, J., McCleland, M., Stawiski, E.W., Gnad, F., Mayba, O., Haverty, P.M., et al. Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer. Nat Commun, 5, 2014, 3830.
41. Ma, X., Wen, L., Wu, L., Wang, Q., Yao, H., Ma, L., et al. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia. Cancer Genet 208 (2015), 52–53.
42. Madigan, A.A., Rycyna, K.J., Parwani, A.V., Datiri, Y.J., Basudan, A.M., Sobek, K.M., et al. Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressiveness. Am J Pathol 184 (2014), 2156–2162.
43. Mardis, E.R., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361 (2009), 1058–1066.
44. Marty, M., Prochazkova, M., Laharanne, E., Chevret, E., Longy, M., Jouary, T., et al. Primary cutaneous T-cell lymphomas do not show specific NAV3 gene deletion or translocation. J Invest Dermatol 128 (2008), 2458–2466.
45. McGirt, L.Y., Jia, P., Baerenwald, D.A., Duszynski, R.J., Dahlman, K.B., Zic, J.A., et al. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood 126 (2015), 508–519.
46. Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., Milne, R.L., et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45 (2013), 353–361 61e1–2.
47. Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470 (2011), 115–119.
48. Noris, P., Favier, R., Alessi, M.C., Geddis, A.E., Kunishima, S., Heller, P.G., et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood 122 (2013), 1987–1989.
49. Olsen, E., Whittaker, S., Kim, Y., Duvic, M., Prince, H., Lessin, S., et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 29 (2011), 2598–2607.
50. Pasqualucci, L., Trifonov, V., Fabbri, G., Ma, J., Rossi, D., Chiarenza, A., et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43 (2011), 830–837.
51. Pérez, C., González-Rincón, J., Onaindia, A., Almaráz, C., García-Díaz, N., Pisonero, H., et al. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma. Haematologica 100 (2015), e450–e453.
52. Puente, X.S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G.R., Villamor, N., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475 (2011), 101–105.
53. Quesada, V., Conde, L., Villamor, N., Ordóñez, G.R., Jares, P., Bassaganyas, L., et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44 (2012), 47–52.
54. Rajala, H.L., Eldfors, S., Kuusanmäki, H., van Adrichem, A.J., Olson, T., Lagström, S., et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood 121 (2013), 4541–4550.
55. Robinson, J.T., Thorvaldsdottir, H., Winckler, W., Guttman, M., Lander, E.S., Getz, G., et al. Integrative genomics viewer. Nat Biotechnol 29 (2011), 24–26.
56. Salgado, R., Servitje, O., Gallardo, F., Vermeer, M.H., Ortiz-Romero, P.L., Karpova, M.B., et al. Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J Invest Dermatol 130 (2010), 1126–1135.
57. Scarisbrick, J.J., Prince, H.M., Vermeer, M.H., Quaglino, P., Horwitz, S., Porcu, P., et al. Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol 33 (2015), 3766–3773.
58. Schmitz, R., Young, R.M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490 (2012), 116–120.
59. Schüle, S., Neuhäuser, C., Rauchfuß, F., Knösel, T., Settmacher, U., Altendorf-Hofmann, A., The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases. Int J Colorectal Dis 29 (2014), 9–14.
60. Sekulic, A., Liang, W.S., Tembe, W., Izatt, T., Kruglyak, S., Kiefer, J.A., et al. Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion. Mol Genet Genomic Med 3 (2015), 130–136.
61. Snel, B., Lehmann, G., Bork, P., Huynen, M.A., STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 28 (2000), 3442–3444.
62. Solé, F., Woessner, S., Vallespi, T., Pérez Losada, A., Florensa, L., Irriguible, D., et al. Cytogenetic studies in five patients with Sézary syndrome. Cancer Genet Cytogenet 75 (1994), 130–132.
63. STRING: protein-protein Interaction Networks. http://string-db.org; 2000 (accessed October 2015).
64. Uehara, T., Kage-Nakadai, E., Yoshina, S., Imae, R., Mitani, S., The tumor suppressor BCL7B functions in the Wnt signaling pathway. PLoS Genet, 11, 2015, e1004921.
65. Ungewickell, A., Bhaduri, A., Rios, E., Reuter, J., Lee, C.S., Mah, A., et al. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2. Nat Genet 47 (2015), 1056–1060.
66. Vaque, J., Gomez-Lopez, G., Monsalvez, V., Varela, I., Martinez, N., Perez, C., et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood 123 (2014), 2034–2043.
67. Vermeer, M.H., van Doorn, R., Dijkman, R., Mao, X., Whittaker, S., van Voorst Vader, P.C., et al. Novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 68 (2008), 2689–2698.
68. Vonderheid, E.C., Bernengo, M.G., Burg, G., Duvic, M., Heald, P., Laroche, L., et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46 (2002), 95–106.
69. Wang, L., Ni, X., Covington, K.R., Yang, B.Y., Shiu, J., Zhang, X., et al. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet 47 (2015), 1426–1434.
70. Wood, L.D., Parsons, D.W., Jones, S., Lin, J., Sjöblom, T., Leary, R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007), 1108–1113.
71. Yasuda, T., Tezuka, T., Maeda, A., Inazu, T., Yamanashi, Y., Gu, H., et al. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells. J Exp Med 196 (2002), 51–63.
72. Yulug, I.G., See, C.G., Fisher, E.M., Ylug, I.G., The DAD1 protein, whose defect causes apoptotic cell death, maps to human chromosome 14. Genomics 26 (1995), 433–435.
73. Zaytseva, Y.Y., Elliott, V.A., Rychahou, P., Mustain, W.C., Kim, J.T., Valentino, J., et al. Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer. Carcinogenesis 35 (2014), 1341–1351.
74. Zinzani, P., Musuraca, G., Tani, M., Stefoni, V., Marchi, E., Fina, M., et al. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. J Clin Oncol 25 (2007), 4293–4297.